|
Today's Headlines
The Society of Thoracic Surgeons has updated its clinical practice guidelines on use of antiplatelet drugs during heart surgery. The new guideline, published in the November 2012 issue of The Annals of Thoracic Surgery, takes into account newly available antiplatelet therapies, new scientific information, and a broader use of antiplatelet drugs such as before lung and vascular procedures, according to Newswise. » Full article
|
|
With President Obama's re-election, implementation of the Affordable Care Act will move forward, full speed ahead, according to one industry expert » Full article
|
|
FDA has expanded the approved use of oral anticoagulant rivaroxaban (Xarelto, Janssen) to include 3 new indications: treatment of deep vein thrombosis (DVT), treatment of pulmonary embolism (PE), and reducing the risk of recurrent DVT and PE following initial treatment. » Full article
|
|
FDA has approved tofacitinib (Xeljanz, Pfizer) to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate.
» Full article
|
|
CONTINUING EDUCATION
Welcome to the third activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The November activity will cover oral antidiabetes agents and noninsulin injectables for diabetes care.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.
|
|
ADVERTISEMENT
PAC Delivers More Predictable GER than AWP -
 click here to see example
New drug price type, Predictive Acquisition Cost (PAC), delivers more predictable and stable generic effective rate (GER) than Average Wholesale Price (AWP).
Click here to see a scenario illustrating how PAC compares to AWP for GER variability across drug groups.See example now. |
|
EDITOR'S PICK
In the quest to adopt personalized medicine approaches, optimizing antiplatelet therapy based on platelet function testing is controversial. But data from a team led by a researcher at the Cleveland Clinic failed to demonstrate improved outcomes following intensification of antiplatelet therapy on the basis of platelet function testing in patients with stroke or transient ischemic attack (TIA). » Full article
|
Survey
a) Further broaden the gap between copay dollar value between preferred and non-preferred brand drug tiers.
b) Demand increase formulary rebates requested from manufacturers of preferred products.
c) Implement more aggressive utilization management (PA, Step, Therapeutic Interchange, etc.) to specifically target these products.
d) Enhanced employment of a closed-formulary benefit design.
e) No action, as I dont believe this couponing will have significant effects.
Respond here and see what your colleagues think too.Want to see the results of our last survey. Click here.
|
|
|
Like
Tweet
